CHRYSCAPITAL

Happy Monday! Investors in new-age startups are set for huge gains as these firms list on the public markets. This and more in today’s ETtech Morning Dispatch.

In the last month, several new-age companies backed by venture capital, have or are set to hit the public markets. This has resulted in a gold rush for their investors. Travel tech platform Ixigo is set to go public next week, while insurtech firm G...

Warburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy's Laboratories are competing to acquire BSV Group, a biopharma firm specializing in women's health and critical care products, indicating a trend of consolidation in th...

Mankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensing deals to enhance its branded formulation business.

Singapore's Temasek and US financial service major Fidelity invest $200 million in Lenskart through a secondary share sale, valuing the company at $5 billion.

ChrysCapital, led by MD Kshitij Sheth, aims to acquire Indian companies in the formulation business with potential valuations of $200 million-$500 million, focusing on growth and eventual public listings.

Swedish investment group EQT has raised $1.6 billion for its latest fund - BPEA EQT Mid-Market Growth Partnership (MMG Fund), focusing on high-growth mid-market companies across Asia, led by Jean Salata, Chairman of EQT Asia.

IPO, which includes a fresh share sale of Rs 128 crore and an offer-for-sale of up to 12.2 million shares, closes on May 24. Around 75% of the IPO is reserved for qualified institutional bidders (QIBs), 15% for non-institutional investors, and the r...

IPOs Next Week: Apart from the new issues, D-Street will see as many as 8 listings including that of the Go Digit General Insurance, which opened for subscription in the week gone by and generated significant enthusiasm among investors, reflecting t...

The company expects its differentiated business model, expanding presence in tier-1 and tier-2 cities and increasing demand from large enterprises and startups to help make its public listing a success and drive future growth, founder and managing d...

Awfis Space Solutions' IPO opens for subscription on May 22, with a price band of Rs 364-383 per share. The offering aims to raise between Rs 576-599 crore, valuing the company at Rs 2,659 crore.

Coworking space company, Awfis Space Solutions, will launch its initial public offering (IPO) on May 22, the company’s red herring prospectus showed.

Coworking space company, Awfis Space Solutions, will launch its initial public offering (IPO) on May 22, the company’s red herring prospectus showed. The Delhi-based company has reduced the fresh capital it is raising from the offering to Rs 128 cro...

Delhi-based Awfis has reduced the fresh capital it is raising from the offering to Rs 128 crore from Rs 160 crore earlier. Meanwhile, the company's offer for sale component (OFS), through which investors like Peak XV Partners and private equity firm...

The Padma Shri awardee, who previously headed the ophthalmology department at All India Institute of Medical Sciences, told ET that he would be among the few entrepreneurs in this sector to remain in control of his company after private equity inves...

ChrysCapital, a domestic PE fund, is set to invest up to Rs 830 crore in New Delhi's Centre for Sight (CFS), a leading eye care chain, partly acquiring Mahindra Holdings Limited's stake. The investment aims to bolster CFS's expansion across India's ...

KKR acquired Healthium Medtech Ltd., a leading Indian medical devices company, from Apax Partners. The deal, valued at approximately Rs 7000 crore, involves a special purpose vehicle owned by KKR-managed funds gaining control of Healthium. Healthium...

Binding agreement signed; formal announcement by early next week, pips rival bidders Mankind Pharma-Chrys Cap Healthium is the largest manufacturer of surgical needles globally by volume.

Indian private equity firm ChrysCapital has raised $700 million in new funds, allowing the firm to maintain its stake in India's National Stock Exchange (NSE) by buying itself out, the firm said Tuesday.